Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT02639065
Title A Study of Durvalumab (MEDI4736) in Esophageal Cancer
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors Shadia Jalal, MD
Indications
Therapies
Age Groups: adult
Covered Countries USA

Facility Status City State Zip Country Details
Indiana University Melvin and Bren Simon Cancer Center Indianapolis Indiana 46202 United States Details
Unversity of Iowa Hospital and Clinics Iowa City Iowa 52242 United States Details
University of Michigan Health System Ann Arbor Michigan 48109 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field